Image-guided convection-enhanced delivery of GDNF protein into monkey putamen

NeuroImage

Volumn 54, Issue SUPPL. 1, 2011, Pages

  Gimenez, Francisco ^a   Krauze, Michal T ^b   Valles, Francisco ^a   Hadaczek, Piotr ^a   Bringas, John ^a   Sharma, Nitasha ^c   Forsayeth, John ^a   Bankiewicz, Krystof S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; GADOTERIDOL; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG INFUSION; MACACA FASCICULARIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROCESS MONITORING; PUTAMEN; THERMODYNAMICS; WHITE MATTER;

ANIMALS; CONTRAST MEDIA; CONVECTION; DRUG DELIVERY SYSTEMS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HETEROCYCLIC COMPOUNDS; MACACA FASCICULARIS; MAGNETIC RESONANCE IMAGING; MALE; ORGANOMETALLIC COMPOUNDS; PUTAMEN; SURGERY, COMPUTER-ASSISTED; TISSUE DISTRIBUTION;

EID: 78650848173     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.01.023     Document Type: Article

References (29)

1. Aoi M., Date I., Tomita S., Ohmoto T. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Neurosci. Res. 2000, 36:319-325.
2. Bankiewicz K.S., Eberling J.L., Kohutnicka M., Jagust W., Pivirotto P., Bringas J., Cunningham J., Budinger T.F., Harvey-White J. Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp. Neurol. 2000, 164:2-14.
3. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2076-2080.
4. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380:252-255.
5. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 2003, 9:589-595.
6. Hadaczek P., Kohutnicka M., Krauze M.T., Bringas J., Pivirotto P., Cunningham J., Bankiewicz K. Convection-enhanced delivery of adeno-associated virus type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain. Hum. Gene Ther. 2006, 17:291-302.
7. Hadaczek P., Yamashita Y., Mirek H., Tamas L., Bohn M.C., Noble C., Park J.W., Bankiewicz K. The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol. Ther. 2006, 14:69-78.
8. Hamilton J.F., Morrison P.F., Chen M.Y., Harvey-White J., Pernaute R.S., Phillips H., Oldfield E., Bankiewicz K.S. Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp. Neurol. 2001, 168:155-161.
9. Hovland D.N., Boyd R.B., Butt M.T., Engelhardt J.A., Moxness M.S., Ma M.H., Emery M.G., Ernst N.B., Reed R.P., Zeller J.R., Gash D.M., Masterman D.M., Potter B.M., Cosenza M.E., Lightfoot R.M. Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys. Toxicol. Pathol. 2007, 35:1013-1029.
10. Johnston L.C., Eberling J., Pivirotto P., Hadaczek P., Federoff H.J., Forsayeth J., Bankiewicz K. Clinically relevant effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Hum. Gene Ther. 2009, 20:1-14.
11. Kells A.P., Hadaczek P., Yin D., Bringas J., Varenika V., Forsayeth J., Bankiewicz K.S. Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2407-2411.
12. Krauze M.T., McKnight T.R., Yamashita Y., Bringas J., Noble C.O., Saito R., Geletneky K., Forsayeth J., Berger M.S., Jackson P., Park J.W., Bankiewicz K.S. Real-time visualization and characterization of liposomal delivery into the monkey brain by magnetic resonance imaging. Brain Res. Brain Res. Protoc. 2005, 16:20-26.
13. Krauze M.T., Saito R., Noble C., Bringas J., Forsayeth J., McKnight T.R., Park J., Bankiewicz K.S. Effects of the perivascular space on convection-enhanced delivery of liposomes in primate putamen. Exp. Neurol. 2005, 196:104-111.
14. Krauze M.T., Forsayeth J., Park J.W., Bankiewicz K.S. Real-time imaging and quantification of brain delivery of liposomes. Pharm. Res. 2006, 23:2493-2504.
15. Krauze M.T., Vandenberg S.R., Yamashita Y., Saito R., Forsayeth J., Noble C., Park J., Bankiewicz K.S. Safety of real-time convection-enhanced delivery of liposomes to primate brain: a long-term retrospective. Exp. Neurol. 2008, 210:638-644.
16. Lang A.E., Gill S., Patel N.K., Lozano A., Nutt J.G., Penn R., Brooks D.J., Hotton G., Moro E., Heywood P., Brodsky M.A., Burchiel K., Kelly P., Dalvi A., Scott B., Stacy M., Turner D., Wooten V.G., Elias W.J., Laws E.R., Dhawan V., Stoessl A.J., Matcham J., Coffey R.J., Traub M. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 2006, 59:459-466.
17. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons [see comments]. Science 1993, 260:1130-1132.
18. Lin L.-F., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 1994, 63:758-768.
19. Lonser R.R., Weil R.J., Morrison P.F., Governale L.S., Oldfield E.H. Direct convective delivery of macromolecules to peripheral nerves. J. Neurosurg. 1998, 89:610-615.
20. Mamot C., Drummond D.C., Hong K., Kirpotin D.B., Park J.W. Liposome-based approaches to overcome anticancer drug resistance. Drug Resist Updat 2003, 6:271-279.
21. Manfredsson F.P., Tumer N., Erdos B., Landa T., Broxson C.S., Sullivan L.F., Rising A.C., Foust K.D., Zhang Y., Muzyczka N., Gorbatyuk O.S., Scarpace P.J., Mandel R.J. Nigrostriatal rAAV-mediated GDNF overexpression induces robust weight loss in a rat model of age-related obesity. Mol. Ther. 2009, 17:980-991.
22. Matcham J., McDermott M.P., Lang A.E. GDNF in Parkinson's disease: the perils of post-hoc power. J. Neurosci. Methods 2007, 163:193-196.
23. Saito R., Krauze M.T., Bringas J.R., Noble C., McKnight T.R., Jackson P., Wendland M.F., Mamot C., Drummond D.C., Kirpotin D.B., Hong K., Berger M.S., Park J.W., Bankiewicz K.S. Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp. Neurol. 2005, 196:381-389.
24. Salvatore M.F., Ai Y., Fischer B., Zhang A.M., Grondin R.C., Zhang Z., Gerhardt G.A., Gash D.M. Point source concentration of GDNF may explain failure of phase II clinical trial. Exp. Neurol. 2006, 202:497-505.
25. Sampson J.H., Brady M.L., Petry N.A., Croteau D., Friedman A.H., Friedman H.S., Wong T., Bigner D.D., Pastan I., Puri R.K., Pedain C. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery 2007, 60. ONS89-98; discussion ONS98-89.
26. Sherer T.B., Fiske B.K., Svendsen C.N., Lang A.E., Langston J.W. Crossroads in GDNF therapy for Parkinson's disease. Mov. Disord. 2006, 21:136-141.
27. Su X., Kells A.P., Huang E.J., Lee H.S., Hadaczek P., Beyer J., Bringas J., Pivirotto P., Penticuff J., Eberling J., Federoff H.J., Forsayeth J., Bankiewicz K.S. Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys. Hum. Gene Ther. 2009, 20:1627-1640.
28. Varenika V., Dickenson P., Bringas J., LeCouteur R., Higgins R., Park J.W., Fiandaca M., Berger M.S., Sampson J.H., Bankiewicz K.S. Real-time imaging of CED in the brain permits detection of infusate leakage. J. Neurosurg. 2008, 109:874-880.
29. Zhang Z., Miyoshi Y., Lapchak P.A., Collins F., Hilt D., Lebel C., Kryscio R., Gash D.M. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. J. Pharmacol. Exp. Ther. 1997, 282:1396-1401.